SAN LUIS OBISPO, Calif.--(BUSINESS WIRE)--FzioMed, Inc., a medical device manufacturer specializing in biomaterials, has received notification from FDA that the Medical Device Dispute Resolution Panel (MDDRP) will convene and make a decision on the approvability of Oxiplex Gel on June 10, 2014.
Help employers find you! Check out all the jobs and post your resume.
